Citations

Mayo Clinic

Clear

51 citation(s) found for "Käll, Mikaela".

D89. Nipple Areolar Malposition versus Ideal Position after Nipple-Sparing Mastectomy Reconstruction
Mendoza, Alessa Mikaela, Hochwald, Alex, Rinker, Brian, TerKonda, Sarvam P. , McLaughlin, Sarah A. , Ho, Olivia A. , Li, Zhuo , Borna, Sahar , Forte, Antonio J. , Jakub, James W.

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 111-111

10.1097/01.gox.0001018840.30925.2a Get It

Proximal Humerus Reconstruction for Bone Sarcomas
Houdek, Matthew T. , Sullivan, Mikaela H. , Broida, Samuel E. , Barlow, Jonathan D. , Moran, Steven L. , Sánchez‐Sotelo, Joaquín , Moran, Steven L , Sanchez-Sotelo, J. , Houdek, Matthew T , Barlow, Jonathan D , Broida, Samuel E , Morrey, Mark E.

JBJS Reviews | March 11, 2024 | Volume: 12 | Issue: 3 | Pages: No page available

10.2106/jbjs.rvw.23.00217 | PMID 38466801 Get It

» The proximal humerus is a common location for primary bone tumors, and the goal of surgical care is to obtain a negative margin resection and subsequent reconstruction of the proximal humerus to allow for shoulder function. » The current evidence supports the use of reverse total shoulder arthroplasty over hemiarthroplasty when reconstructing the proximal humerus after resection of a bone sarcoma if the axillary nerve can be preserved. » There is a lack of high-quality data comparing allograft prosthetic composite (APC) with endoprosthetic reconstruction of the proximal humerus. » Reverse APC should be performed using an allograft with donor rotator cuff to allow for soft-tissue repair of the donor and host rotator cuff, leading to improvements in shoulder motion compared with an endoprosthesis.
Current practice focus trends in physical medicine and rehabilitation
Kinney, Carolyn L. , Pruitt, David W. , Francisco, Gerard E. , Raddatz, Mikaela M. , Sabharwal, Sunil , Kinney, Carolyn , Pruitt, David W

PM&R | December 20, 2023 | Volume: 16 | Issue: 7 | Pages: 738-744

10.1002/pmrj.13119 | PMID 38115622 Get It

Abstract Background Physical medicine and rehabilitation (PM&R) is a diverse specialty, growing and evolving over a variety of subspecialty and practice focus areas. Accurate data regarding practice patterns of physiatrists are essential for updating requirements in training and certification, particularly as the Accreditation Council for Graduate Medical Education begins its process to update of the PM&R core residency training requirements. This study analyzes practice trends for nearly 98% of physiatrists in active practice, the largest study to date. Objective To update current demographics of physicians specializing in PM&R, including current areas of practice focus, to analyze the alignment of practice focus with subspecialty certification, and to determine the extent that electromyography is a component of current physiatric practice. Design Retrospective analysis of deidentified responses from American Board of Physical Medicine and Rehabilitation (ABPMR) board‐certified PM&R physicians (diplomates) on annual enrollment in the ABPMR Continuing Certification program. Participants A total of 9543 ABPMR diplomates. Main Outcome Measures Demographics – age, gender, years in practice, practice setting(s) and area(s). Practice focus, subspecialty certifications. Results The majority of practicing physiatrists are men (62%) although the percentage of women in the field is growing (38%). Nearly 80% of physiatrists report more than one practice focus area, with pain medicine and sports medicine/musculoskeletal practices most commonly reported. Conclusions This study confirms the growth trends in PM&R in pain and sports medicine but also highlights the substantial number of physiatrists focusing their practices in areas related to neurorehabilitation and medical rehabilitation. The large majority of physiatrists incorporate multiple focus areas into their practices. Electromyography is a focus for a declining percentage of practicing physiatrists.
Oncological and functional outcomes after resection of malignant tumours of the scapula
Sullivan, Mikaela H. , Sánchez‐Sotelo, Joaquín , Rose, Peter S. , Houdek, Matthew T. , Morrey, Mark, Sanchez-Sotelo, J. , Houdek, Matthew T , Broida, Samuel E. , Barlow, Jonathan D. , Morrey, Mark E. , Scorianz, Maurizio , Wagner, Eric R.

The Bone & Joint Journal | December 1, 2023 | Volume: 105-B | Issue: 12 | Pages: 1314-1320

10.1302/0301-620x.105b12.bjj-2023-0552.r1 | PMID 38035605 Get It

AimsThe scapula is a rare site for a primary bone tumour. Only a small number of series have studied patient outcomes after treatment. Previous studies have shown a high rate of recurrence, with functional outcomes determined by the preservation of the glenohumeral joint and deltoid. The purpose of the current study was to report the outcome of patients who had undergone tumour resection that included the scapula.MethodsWe reviewed 61 patients (37 male, 24 female; mean age 42 years (SD 19)) who had undergone resection of the scapula. The most common resection was type 2 (n = 34) according to the Tikhoff-Linberg classification, or type S1A (n = 35) on the Enneking classification.ResultsThe ten-year disease-specific survival was 76%. High tumour grade (hazard ratio (HR) 4.27; p = 0.016) and a total resection of the scapula (HR 3.84; p = 0.015) were associated with worse survival. The ten-year metastasis-free and local recurrence-free survivals were 82% and 86%, respectively. Total scapular resection (HR 6.29; p = 0.004) was associated with metastatic disease and positive margins were associated with local recurrence (HR 12.86; p = 0.001). At final follow-up, the mean shoulder forward elevation and external rotation were 79° (SD 62°) and 27° (SD 25°), respectively. The most recent functional outcomes evaluated included the mean Musculoskeletal Tumor Society Score (76% (SD 17%)), the American Shoulder and Elbow Score (73% (SD 20%)), and the Simple Shoulder Test (7 (SD 3)). Preservation of the glenoid (p = 0.001) and scapular spine (p < 0.001) improved clinical outcomes; interestingly, preservation of the scapular spine without the glenoid improved outcomes (p < 0.001) compared to preservation of the glenoid alone (p = 0.05).ConclusionResection of the scapula is a major undertaking with an oncological outcome related to tumour grade, and a functional outcome associated with the status of the scapular spine and glenoid. Positive resection margins are associated with local recurrence.Cite this article: Bone Joint J 2023;105-B(12):1314–1320.
Evidence-based Indications for Vertebral Body Tethering in Spine Deformity
Sullivan, Mikaela H. , Jackson, Taylor J. , Milbrandt, Todd A. , Kepler, Christopher K. , Sebastian, Arjun S. , Larson, Annalise Noelle, Larson, A. Noelle

Clinical Spine Surgery | September 9, 2023 | Volume: 37 | Issue: 3 | Pages: 82-91

10.1097/bsd.0000000000001521 | PMID 37684718 Get It

Posterior spinal fusion has long been established as an effective treatment for the surgical management of spine deformity. However, interest in nonfusion options continues to grow. Vertebral body tethering is a nonfusion alternative that allows for the preservation of growth and flexibility of the spine. The purpose of this investigation is to provide a practical and relevant review of the literature on the current evidence-based indications for vertebral body tethering. Early results and short-term outcomes show promise for the first generation of this technology. At this time, patients should expect less predictable deformity correction and higher revision rates. Long-term studies are necessary to establish the durability of early results. In addition, further studies should aim to refine preoperative evaluation and patient selection as well as defining the benefits of motion preservation and its long-term effects on spine health to ensure optimal patient outcomes.
COVID‐19 and abortion in the Ohio River Valley: A case study of Kentucky, Ohio, and West Virginia
Smith, Mikaela H. , Broscoe, Molly, Hill, Jessie , Hood, Robert B. , McGowan, Michelle L. , Norris, Alison H. , McGowan, Michelle, Chakraborty, Payal , Bessett, Danielle

Perspectives on Sexual and Reproductive Health | August 12, 2023 | Volume: 55 | Issue: 3 | Pages: 178-191

10.1363/psrh.12244 | PMID 37571959 Get It

AbstractIntroductionDuring early stages of COVID‐19 in the United States, government representatives in Kentucky, Ohio, and West Virginia restricted or threatened to restrict abortion care under elective surgery bans. We examined how abortion utilization changed in these states.MethodologyWe examined COVID‐19 abortion‐related state policies implemented in March and April 2020 using publicly available sources. We analyzed data on abortions by method and gestation and experiences of facility staff, using a survey of 14 facilities. We assessed abortions that took place in February–June 2020 and February–June 2021.ResultsIn February–June 2020 the monthly average abortion count was 1916; 863 (45%) were medication abortions and 229 (12%) were ≥14 weeks gestation. Of 1959 abortions performed across all three states in April 2020, 1319 (67%) were medication abortions and 231 (12%) were ≥14 weeks gestation. The shift toward medication abortion that took place in April 2020 was not observed in April 2021. Although the total abortion count in the three‐state region remained steady, West Virginia had the greatest decline in total abortions, Ohio experienced a shift from instrumentation to medication abortions, and Kentucky saw little change. Staff reported increased stress from concerns over health and safety and increased scrutiny by the state and anti‐abortion protesters.DiscussionAlthough abortion provision continued in this region, policy changes restricting abortion in Ohio and West Virginia resulted in a decrease in first trimester instrumentation abortions, an overall shift toward medication abortion care, and an increase in stress among facility staff during the early phase of COVID‐19.
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
Mascarenhas, John , Migliaccio, Anna Ritá , Kosiorek, Heidi , Bhave, Rupali , Palmer, Jeanne , Mesa, Ruben A. , Rampal, Raajit K. , Gerds, Aaron T. , Yacoub, Abdulraheem , Pettit, Kristen , Kremyanskaya, Marina , Gonzalez, Agapito , Fabris, Frank , Johnson, Kathryn , Dougherty, Mikaela , Domenico, Dylan , Farnoud, Noushin , Weinberg, Rona Singer , Kong, Amy , Najfeld, Vesna , Arciprete, Francesca , Falchi, Mario , Salama, Mohamed E. , Mead‐Harvey, Carolyn , Dueck, Amylou C. , Varricchio, Lilian , Dueck, A. C. , Kuykendall, Andrew , Mesa, Ruben , Rampal, Raajit K , Gerds, Aaron T , Yacoub, Abdulraheem , Pettit, Kristen , Talpaz, Moshe , Komrokji, Rami S , Kremyanskaya, Marina , Gonzalez, Agapito , Fabris, Frank , Johnson, Kathryn , Dougherty, Mikaela , McGovern, Erin , Arango Ossa, Juan E , Domenico, Dylan , Farnoud, Noushin , Weinberg, Rona Singer , Kong, Amy , Najfeld, Vesna , Vannucchi, Alessandro M , Arciprete, Francesca , Zingariello, Maria , Falchi, Mario , Salama, Mohamed E , Mead-Harvey, Carolyn , Varricchio, Lilian , Hoffman, Ronald , Mascarenhas, John , Kosiorek, Heidi E , Talpaz, Moshe , Komrokji, Rami S. , McGovern, Erin , Ossa, Juan Arango , Vannucchi, Alessandro M.

Clinical Cancer Research | July 13, 2023 | Volume: 29 | Issue: 18 | Pages: 3622-3632

10.1158/1078-0432.ccr-23-0276 | PMID 37439808 Get It

Abstract Purpose: Myelofibrosis (MF) is a clonal myeloproliferative neoplasm characterized by systemic symptoms, cytopenias, organomegaly, and bone marrow fibrosis. JAK2 inhibitors afford symptom and spleen burden reduction but do not alter the disease course and frequently lead to thrombocytopenia. TGFβ, a pleiotropic cytokine elaborated by the MF clone, negatively regulates normal hematopoiesis, downregulates antitumor immunity, and promotes bone marrow fibrosis. Our group previously showed that AVID200, a potent and selective TGFβ 1/3 trap, reduced TGFβ1-induced proliferation of human mesenchymal stromal cells, phosphorylation of SMAD2, and collagen expression. Moreover, treatment of MF mononuclear cells with AVID200 led to increased numbers of progenitor cells (PC) with wild-type JAK2 rather than JAK2V617F. Patients and Methods: We conducted an investigator-initiated, multicenter, phase Ib trial of AVID200 monotherapy in 21 patients with advanced MF. Results: No dose-limiting toxicity was identified at the three dose levels tested, and grade 3/4 anemia and thrombocytopenia occurred in 28.6% and 19.0% of treated patients, respectively. After six cycles of therapy, two patients attained a clinical benefit by IWG-MRT criteria. Spleen and symptom benefits were observed across treatment cycles. Unlike other MF-directed therapies, increases in platelet counts were noted in 81% of treated patients with three patients achieving normalization. Treatment with AVID200 resulted in potent suppression of plasma TGFβ1 levels and pSMAD2 in MF cells. Conclusions: AVID200 is a well-tolerated, rational, therapeutic agent for the treatment of patients with MF and should be evaluated further in patients with thrombocytopenic MF in combination with agents that target aberrant MF intracellular signaling pathways.
Pedicled Functional Latissimus Flaps for Reconstruction of the Upper Extremity following Resection of Soft-Tissue Sarcomas
Arguello, Alexandra M. , Sullivan, Mikaela H. , Mills, Gavin L. , Moran, Steven L. , Houdek, Matthew T. , Houdek, Matthew T

Current Oncology | March 7, 2023 | Volume: 30 | Issue: 3 | Pages: 3138-3148

10.3390/curroncol30030237 | PMID 36975450 Get It

(1) Background: Resection of soft-tissue sarcomas (STS) of the upper extremity can result in substantial functional impairment with limited options for functional reconstruction. Free functional latissimus flaps have been utilized to restore function of the thigh; however, there is limited data on the use of latissimus flaps for functional reconstruction in the upper extremity. As such, we sought to evaluate our institutional experience with these flaps. (2) Methods: We reviewed ten (seven male; three female; and a mean age of 63 years) patients undergoing soft-tissue sarcoma resection involving the triceps (n = 4), biceps (n = 4), and deltoid (n = 2) reconstructed with a pedicled functional latissimus flap. All surviving patients had at least 1 year of follow-up, with a mean follow-up of 5 years. (3) Results: The mean elbow range of motion and shoulder elevation were 105° and 150°. The mean Musculoskeletal Tumor Society score was 88%, and the muscle strength was four. Four patients had a recipient site wound complication. There were no flap losses. One patient sustained a radiation-associated humerus fracture 5 years postoperatively, treated nonoperatively. (4) Conclusions: Although early complications are high, pedicled functional latissimus flaps allow for wound coverage, potential space obliteration, and restoration of function in the upper extremity following resection of large soft tissue sarcomas.
Safe management of carotid body tumor resection without preoperative embolization: an Ecuadorian high-altitude cities experience
Solis-Pazmino, Paola , Tite, Belen, García, Mikaela, Godoy, Richard, Rocha, Carla , Ponce, Oscar J. , Dy, Benzon M. , García, Cristhian, Solís-Pazmiño, Paola , Ponce, Oscar Josue , Pilatuna, Eduardo A , Godoy, Richard

Journal of Surgical Case Reports | December 21, 2022 | Volume: 2022 | Issue: 12 | Pages: No page available

10.1093/jscr/rjac598 | PMID 36570551 Get It

Abstract Carotid body tumors (CBTs) are a neoplasm that affects the carotid glomus. This study aims to improve the management of CBTs in Ecuador. This single-center, retrospective observational study was conducted at the Instituto de la Tiroides y Enfermedades de Cabeza y Cuello (ITECC). We included adults with CBTs, between January 2019 and August 2022. A total of 15 patients with CBTs were included. All patients were females living at high altitudes (&gt;2500 m). In the Shamblin classification, 12 tumors were type II, and 3 were type III. Complete tumor resection was performed in all patients without pre-operative embolization. All patients had benign CBTs with a mean follow-up of 17, 73 months. In a time when the medical cost is high mainly in low-income countries such as Ecuador, further investigation should be undertaken in the form of randomized prospective trials to answer who would benefit from the pre-TAE procedure.
Molecularly Targeted Combination Therapy for Advanced Phase Myeloproliferative Neoplasm: MPN-RC 119
Bar‐Natan, Michal , Kremyanskaya, Marina , Dougherty, Mikaela , Fabris, Frank , Johnson, Kathryn, Yu, Ashley , Mead‐Harvey, Carolyn , Rampal, Raajit K. , Mascarenhas, John , Gerds, Aaron T. , Mesa, Ruben A. , Gupta, Vikas , Kosiorek, Heidi , Dueck, Amylou C. , Hoffman, Ronald

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3988-3990

10.1182/blood-2022-164678 Get It